Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Wesana Health Hldgs Inc (OP:WSNAF)

0.0116 UNCHANGED

Streaming Delayed Price Updated: 12:22 PM EST, Feb 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,041
Open	0.0116
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0116
Today's Range	0.0116 - 0.0163
52wk Range	0.0042 - 0.1300
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More ↗

July 11, 2023

First Country Allowing MDMA & Psilocybin For Depression, PTSD Makes Headlines On Saturday, July 1, 2023, Australia became the first country to allow physicians to prescribe MDMA to treat post-traumatic...

Via Benzinga

Wesana Shareholders Vote For Psilocybin And CBD Therapy Asset Sales To Lucy Scientific ↗

June 12, 2023

Psychedelics drug developer Wesana Health Holdings Inc. (OTCQB: WSNAF) announced all matters discussed at the company’s annual general and special shareholders meeting of June 9 were approved by a...

Via Benzinga

Performance

YTD	-31.8%	-31.8%
1 Month	-9.4%	-9.4%
3 Month	+9.4%	+9.4%
6 Month	-62.1%	-62.1%
1 Year	-83.9%	-83.9%

More News

Disney, Amgen, First Republic, Psychedelics: How One CEO's Universal Deal-Making Approach Shapes Industries ↗

June 05, 2023

Via Benzinga

EXCLUSIVE: Infrastructure Built For Healing: 'Consolidation And Legitimacy Are Crucial For Psychedelic Industry Growth' ↗

April 13, 2023

Via Benzinga

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗

April 03, 2023

Via Benzinga

High-Profile Highs: How Celebrity Advocacy Is Transforming Society's Views On Psychedelics And Cannabis ↗

March 29, 2023

Via Benzinga

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More ↗

March 27, 2023

Via Benzinga

Lucy Scientific Shares Trading Higher On Asset Purchase Agreement Of Psychedelic Assets From Wesana Health ↗

March 21, 2023

Via Benzinga

NGOs Raise Money To Help Stem Opioid Addiction With Psychedelics Program ↗

October 19, 2022

Via Benzinga

Wesana Sells Clinic Management Services Organization To Strengthen Assets ↗

September 02, 2022

Via Benzinga

4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed ↗

August 30, 2022

Via Benzinga

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Via Benzinga

Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage ↗

April 25, 2022

Via Benzinga

Daniel Carcillo Explains How Wesana Health Is Using Psychedelics To Treat Traumatic Brain Injury ↗

April 20, 2022

Via Benzinga

EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space ↗

April 19, 2022

Via Benzinga

Wesana Health One Step Closer To Clinical Trials Of Psilocybin And CBD Based Treatment Of Brain Injury Related MDD ↗

March 14, 2022

Via Benzinga

Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS ↗

January 18, 2022

Via Benzinga

Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana ↗

January 11, 2022

Via Benzinga

The Legacy Of Dr. Aaron Beck, Father Of Cognitive Therapy, Lives On In Psychedelic Medicine ↗

November 04, 2021

Via Benzinga

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗

October 18, 2021

Via Benzinga

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗

October 13, 2021

Via Benzinga

Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial ↗

September 20, 2021

Via Benzinga

Can MDMA Treat Traumatic Brain Injury? $1.5 Million Are Being Committed To Finding Out ↗

September 14, 2021

Via Benzinga

Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M ↗

August 16, 2021

Via Benzinga

Frequently Asked Questions

Is Wesana Health Hldgs Inc publicly traded?

Yes, Wesana Health Hldgs Inc is publicly traded.

What exchange does Wesana Health Hldgs Inc trade on?

Wesana Health Hldgs Inc trades on the OTC Traded

What is the ticker symbol for Wesana Health Hldgs Inc?

The ticker symbol for Wesana Health Hldgs Inc is WSNAF on the OTC Traded

What is the current price of Wesana Health Hldgs Inc?

The current price of Wesana Health Hldgs Inc is 0.0116

When was Wesana Health Hldgs Inc last traded?

The last trade of Wesana Health Hldgs Inc was at 02/06/26 12:22 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.